ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.13, sa.3, ss.245-250, 2013 (SCI-Expanded)
Objective: There is conflicting data about the role of renin-angiotensin-aldosterone system (RAAS) blockers in contrast-induced nephropathy (CIN) pathophysiology. In this study, we aimed to investigate the effects of chronic usage of RAAS blocker drugs on development of CIN in low risk patients.